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Progress in understanding the underlying neurobiology of obsessive-compulsive disorder (OCD) has stalled in part
because of the considerable problem of heterogeneity within this diagnostic category, and homogeneity across other
putatively discrete, diagnostic categories. As psychiatry begins to recognize the shortcomings of a purely symptom-
based psychiatric nosology, new data-driven approaches have begun to be utilized with the goal of solving these
problems: speciﬁcally, identifying trans-diagnostic aspects of clinical phenomenology based on their association with
neurobiological processes. In this review, we describe key methodological approaches to understanding OCD from
this perspective and highlight the candidate traits that have already been identiﬁed as a result of these early endeavours.
We discuss how important inferences can be made from pre-existing case-control studies as well as showcasing newer
methods that rely on large general population datasets to reﬁne and validate psychiatric phenotypes. As exemplars, we
take ‘compulsivity’ and ‘anxiety’, putatively trans-diagnostic symptom dimensions that are linked to well-deﬁned neuro-
biological mechanisms, goal-directed learning and error-related negativity, respectively. We argue that the identiﬁcation
of biologically valid, more homogeneous, dimensions such as these provides renewed optimism for identifying reliable
genetic contributions to OCD and other disorders, improving animal models and critically, provides a path towards a
future of more targeted psychiatric treatments.
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Introduction
The mainstay of psychiatric research is the case-control
methodology whereby a group of individuals meeting
the criteria for a disorder deﬁned by the Diagnostic
and Statistical Manual of Mental Disorders, 5th edn
(DSM-5; APA, 2013) is compared to a group of healthy
controls. Although the DSM has proven extremely use-
ful in establishing a reliable psychiatric nosology that
can be applied in a systematic way across centres
(Regier et al. 2013), and that has led to the widespread
development of evidence-based treatments, it has been
suggested that shortcomings in the use of these cat-
egories for basic research are at least partly responsible
for the lack of speciﬁc and robust associations between
psychopathology and underlying neurobiological pro-
cesses (Hyman, 2007; Sanislow et al. 2010).
Obsessive-compulsive disorder (OCD), is a chronic,
costly and disabling brain disorder for which existing
treatments usually produce disappointing outcomes
(Fineberg et al. 2014). It is deﬁned in DSM-5 (APA,
2013) by the presence of obsessions and/or compul-
sions that are time consuming, distressing or disabling.
Obsessions are repetitive thoughts, urges or images
that are intrusive and unwanted, and that in most indi-
viduals cause anxiety or distress, for example recurrent
thoughts about accidental death. They are associated
with attempts by the individual to suppress or neutral-
ize them with a compulsion. Compulsions are repeti-
tive mental or overt acts that are experienced as
being urge-driven either in response to an obsession
or according to a rule that must be rigidly applied,
and that are aimed at preventing or reducing anxiety
or distress or preventing a feared event from happen-
ing. However, the compulsion either is not connected
in a realistic way with the outcome it is designed to
prevent, or is clearly excessive, such as a driver
retracing their route to check for signs of an accident
after experiencing a minor bump in the road.
DSM-5 acknowledges that these symptoms are not
unique to OCD; outlining 14 other disorders (or dis-
order classes) whose symptoms also broadly ﬁt these
criteria, which the clinician must consider in the
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context of differential diagnosis. These disorders
include other members of the obsessive-compulsive
and related disorders family, in which obsessions
and compulsions are focused either on bodily appear-
ance (body dysmorphic disorder), grooming (trichotil-
lomania and skin picking disorder) or the acquisition
of and/or inability to discard personal items (hoarding
disorder). Eating disorders are also characterized by
behaviours that resemble obsessions and compulsions
focused around body size and weight, whereas
patients with generalized anxiety disorder (GAD)
and depressive disorders experience intrusive, distres-
sing ruminations that are similar to obsessions but are
respectively focused on future or past mishaps. In the
case of addictive disorders, the urge-driven addictive
behaviours become increasingly rigid, stereotyped
and compulsive over time, as their function changes
from reward-seeking to preventing or neutralizing
the distress associated with craving and withdrawal
(Everitt et al. 2001).
In OCD, the level of insight varies considerably from
good to absent both between patients and within the
same patient over time. Poor insight has been asso-
ciated with treatment resistance (Jacob et al. 2014).
Intrusive, irrational thoughts frequently accompany
schizophrenia spectrum and other psychotic disorders,
and it can be difﬁcult to distinguish obsessions from
delusions, based on phenomenology alone. Moreover,
approximately 30% of schizophrenia cases report
obsessive-compulsive symptomatology and 14% have
been found to have OCD (Swets et al. 2014). Some
other individuals develop OCD symptoms as a
result of environmental factors such as Paediatric
Autoimmune Neuropsychiatric Disorder Associated
with Streptococcus (PANDAS; Snider & Swedo, 2003).
Even after careful attempts at differential diagnosis
of OCD, co-morbidity is present in the majority of
cases (Ruscio et al. 2010). Other psychiatric disorders,
including anxiety, somatoform, impulse control,
trauma-related, substance use, and personality disor-
ders, are very common among patients with OCD
and can affect adherence and response to treatment
(Pallanti et al. 2011; Torres et al. 2016). Approximately
three quarters of individuals with OCD in an epi-
demiological sample experienced either an anxiety dis-
order or an affective disorder (Fineberg et al. 2013a).
Most forms of co-morbidity increase distress and
impact negatively on family and work relationships,
however, disorder-speciﬁc effects have also been
observed. For example, agoraphobia and GAD were
associated with increased OCD severity; bipolar dis-
order was associated with suicidal acts and panic dis-
order increased treatment-seeking behaviour (Fineberg
et al. 2013a). In the case of selective serotonin re-uptake
inhibitor (SSRI)-resistant OCD, a preferential effect for
treatment with dopamine antagonists was seen for
those with co-morbid tics (Bloch et al. 2006). These
ﬁndings indicate quite clearly that these and other dis-
orders are not discrete entities, and that the lines
between different DSM diagnoses are often blurred
(Fig. 1).
The issue of homogeneity across diagnostic categor-
ies is coupled with a related problem, heterogeneity
within diagnostic categories. In the case of OCD,
there is a mosaic of diverse phenomenological manifes-
tations (Torres, 2016). A number of authors have
attempted to group these phenomenological variables
into a smaller number of relatively homogeneous, tem-
porally stable symptom dimensions, using factor ana-
lysis of large symptom datasets. This has produced a
multidimensional model of OCD that includes sym-
metry/ordering, hoarding, contamination/cleaning,
and obsessions/checking) (Mataix-Cols et al. 2005; van
den Heuvel et al. 2009). The authors propose these
symptom dimensions should be understood as a spec-
trum of potentially overlapping syndromes that may
(1) co-exist in any patient, (2) be continuous with nor-
mal obsessive-compulsive phenomena, and (3) extend
beyond OCD. Although twin studies suggest there
might be a genetic inﬂuence on dimension-speciﬁc
risk (van Grootheest et al. 2008; Iervolino et al. 2011),
the neurobiological validity of most of these factors
has been difﬁcult to demonstrate, owing to, for
example, the lack of cross-study consistency of brain
structural abnormalities associated with the various
subtypes (Pujol et al. 2004; van den Heuvel et al.
2009; Alvarenga et al. 2012; de Wit et al. 2014). The
hoarding dimension has proven very useful however,
showing a consistently worse response to treatment
than other forms of OCD (Mataix-Cols et al. 1999;
Cullen et al. 2007). This particularly impactful ﬁnding
has provoked a change in DSM-5, such that hoarding
symptoms no longer exclusively contribute to a diag-
nosis of OCD, and are additionally captured by a sep-
arate category, ‘hoarding disorder’. Unfortunately,
hoarding symptoms do not account for all of the het-
erogeneity of treatment response in OCD, where for
example one meta-analysis determined that the num-
ber needed to treat varied from 6–12 for SSRIs com-
pared to placebo (Soomro et al. 2008).
The noisy response to treatment that remains to be
bridged is likely to be a result of mechanistic heterogen-
eity within the OCD population that we cannot easily
identify by analysing symptoms alone. In response,
some researchers have called for a shift away from
the use of DSM categories, in favour of establishing
new and biologically relevant trans-diagnostic traits
that may play an important role in multiple disorders,
as we currently deﬁne them (Robbins et al. 2012;
Cuthbert & Kozak, 2013). The goal of such an
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enterprise is to permit evidence-based drug discovery,
the development of robust animal models, and eventu-
ally realize a future of precision medicine in psych-
iatry. In a wider context, improved nosology based
on more objective tests and criteria would lead to
more homogeneous populations of patients for clinical
trials, more accurate phenotypes for psychiatric
genetics, and the potential for detection of early vul-
nerability, allowing for early therapeutic interventions
that prevent progression to chronic illness.
The National Institute of Mental Health (NIMH) has
been an important leader in this regard, launching its
Research Domain Criteria (RDoC) initiative (Insel
et al. 2010), a framework based on the premise that
Fig. 1. Data from 706 obsessive-compulsive disorder (OCD) patients re-plotted with permission from Nestadt and colleagues
(2009). Disorders assessed were obsessive-compulsive personality disorder (OCPD), generalized anxiety disorder (GAD),
major depression (recurrent), tics, pathological skin picking, separation anxiety disorder, pathological nail biting, panic
disorder, alcohol dependence, body dysmorphic disorder, substance dependence, trichotillomania, hypochondriasis, bipolar
disorder. (a) Co-morbidity rates in a sample of OCD cases – 87.3% of patients met the criteria for another DSM diagnosis
(note: this ﬁgure is probably higher as only select diagnoses were assessed). (b) The prevalence of speciﬁc co-morbid disorders
within the OCD cohort.
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clinical constructs should be deﬁned (and therefore
investigated) on the basis of their neurobiological val-
idity. This review will outline such a trans-diagnostic
framework for understanding the DSM-5 diagnosis of
OCD, outlining putative traits that link genes, mole-
cules, cells, circuits, physiology, behaviour, self-reports
and paradigms to clinical phenomenology. The goal is
to highlight how a trans-diagnostic approach can shed
light on some key puzzles in OCD research, and in so
doing showcase the value that can be derived from
existing case-control investigations and how this can
inform newer attempts at trans-diagnostic psychiatry.
Structurally, we will draw heavily on the NIMH’s
RDoC concepts and criteria, but acknowledge that
other new initiatives such as the Roadmap for Mental
Health Research (ROAMER) is promoting a similar
trans-diagnostic approach (Goschke, 2014). More
broadly, we hope to convey the importance of bridging
the old with the new. RDoC should be applauded for
its focus on biological reality, but perhaps goes too
far by ignoring symptom-based approaches entirely.
In psychiatry, the symptoms cause the suffering and
our focus should remain on understanding and redu-
cing these symptoms, as the patient experiences them.
Case-control studies point to trans-diagnostic
mechanisms in OCD: error-related negativity (ERN)
and anxiety
Can OCD be better understood and treated from a
dimensional perspective? Evidence for this comes
from many sources (Hyman, 2010); of these, perhaps
the most compelling (and frustrating) is the lack of spe-
ciﬁcity of various neurocognitive deﬁcits observed in
OCD (Endrass & Ullsperger, 2014; Fineberg et al.
2014). For example, ‘response inhibition’, the ability
to cancel a prepotent motor response assayed using
the stop-signal reaction-time task (Logan, 1994), is reli-
ably impaired in not just OCD, but also attention
deﬁcit hyperactivity disorder (ADHD) and schizophre-
nia (Lipszyc & Schachar, 2010). Pessimistically, one
might conclude from this lack of speciﬁcity that our
current neurocognitive markers are not useful for
understanding the aetiology of OCD. Perhaps these
markers reﬂect generalized executive impairment, a
consequence of having any psychiatric disorder and
the burdens thereof. Perhaps these markers are not
diagnostic of any speciﬁc mental health issue, but sim-
ply place individuals into an at-risk state for many.
What we will consider in the following sections is an
admittedly well-trodden alternative: that it is our psy-
chiatric taxonomy, not our neurocognitive models, that
presents a problem for research and that the speciﬁcity
of any neurocognitive model of a psychiatric diagnosis
is fundamentally limited by the extent to which that
diagnosis is biologically valid.
How can we determine if a neurocognitive model is
speciﬁc to a trans-diagnostic phenotype, if not one of
the existing DSM disorder categories? What does this
mean for interpreting the results of prior work in
these DSM diagnosed patient populations? A reason-
able starting point is to ﬁrst identify a model of bio-
logical relevance (e.g. neurocognitive or physiological
marker) that exhibits partial speciﬁcity for psychiatric
disorders that is perhaps not speciﬁc to one disorder,
but certainly not common to all. One can then qualita-
tively identify phenotypic commonalities across the
disorders that exhibit mechanistic commonalities and
thus formulate hypotheses about trans-diagnostic phe-
notypes (Robbins et al. 2012; Fineberg et al. 2014).
Publication bias is an obstacle here as studies showing
no difference between patient cohorts and controls,
which are needed to make a case for speciﬁcity, are
less likely to be published or even submitted for pub-
lication (Rosenthal, 1979). One solution (albeit imper-
fect) to this problem is studying multiple disorders at
once, thereby allowing for direct statistical comparison
of disorders that have established deﬁcits in a given
domain and disorders that are hypothesized to be no
different from controls. Failing this, one can gain
insights by leveraging cases where a given neurocogni-
tive mechanism is signiﬁcantly enhanced in one cluster
of disorders, but deﬁcient in another (thereby avoiding
publication bias), as is the case for one very promising
neurocognitive deﬁcit in OCD that we will discuss in
some detail, ERN (Endrass & Ullsperger, 2014).
The ERN is a negative deﬂection of the event-
related potential (ERP) when subjects make an error
(Falkenstein et al. 1991), listed as the RDoC sub-
construct ‘Performance Monitoring’. It is typically
measured using electroencephalogram, but functional
imaging has been coupled with this technique to
conﬁrm that the ERN has its source in the anterior cin-
gulate cortex (ACC) (Debener et al. 2005). A host of
studies have found enhanced ERN in OCD (Gehring
et al. 2000; Johannes et al. 2001b; Ruchsow et al. 2005,
2007; Endrass et al. 2008, 2010, 2014; Hajcak et al.
2008; Stern et al. 2010; Riesel et al. 2011, 2015; Xiao
et al. 2011; Hanna et al. 2012; Carrasco et al. 2013a, b;
Grützmann et al. 2014; Klawohn et al. 2014; Liu et al.
2014) (but see Nieuwenhuis et al. 2005; Agam et al.
2014; Mathews et al. 2015; Weinberg et al. 2015), GAD
(Ladouceur et al. 2006; Weinberg et al. 2012, 2015,
2010) (but see Xiao et al. 2011), social anxiety disorder
(Endrass et al. 2014) and depression (Chiu & Deldin,
2007; Holmes & Pizzagalli, 2008, 2010; Georgiadi
et al. 2011; Aarts et al. 2013; Tang et al. 2013; Mueller
et al. 2015) (although less consistently than in general-
ized anxiety or OCD, see Ruchsow et al. 2004, 2006;
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Olvet et al. 2010; Georgiadi et al. 2011; Weinberg et al.
2012) (Table 1). Accounts regarding the precise func-
tion of ERN are varied (Holroyd & Coles, 2002;
Yeung et al. 2004), but studies have shown that the
ERN primes defensive responses, for example by
potentiating startle responses (Hajcak & Foti, 2008)
and encouraging avoidance behaviour (Frank et al.
2005). Together with a qualitative examination of the
symptom commonalities across these disorders, this
suggests that anxiety might be a reasonable candidate
for consideration as a dimensional phenotype related
to these deﬁcits. This thesis is supported by work in
non-clinical samples, wherein the magnitude of the
ERN is associated with self-reported worry (Hajcak
et al. 2003; Zambrano-Vazquez & Allen, 2014), high
levels of trait anxiety (Paulus et al. 2004) and
OC-symptoms (Hajcak & Simons, 2002; Zambrano-
Vazquez & Allen, 2014). The effect appears to be trait
(rather than state) dependent; the ERN remains
enhanced following successful treatment in both adult
and paediatric OCD (Hajcak et al. 2008; Riesel et al.
2015), does not differ as a result of chronic medication
(Stern et al. 2010) and an enhanced ERN has been
observed in unaffected ﬁrst-degree relatives of both
adult and paediatric OCD sufferers (Riesel et al. 2011;
Carrasco et al. 2013a), suggesting that this may be an
important endophenotype that predisposes individuals
to a range of disorders that involve anxiety.
Critically, the postulate that an enhanced ERN is a
useful marker of an anxious phenotype rests on the
speciﬁcity of this effect. We can begin to, albeit imper-
fectly, approach this issue using existing work in diag-
nosed patients – speciﬁcally if enhanced ERN is
observed in disorders not in part characterized by
pathological anxiety, then this suggests there is more
evidence for the pessimistic view suggested earlier.
Fortunately, evidence for such speciﬁcity is abundant
for this particular neurocognitive marker; a large
body of work has showed that a signiﬁcantly decreased
ERN magnitude is characteristic of a putatively distinct
cluster (or clusters) of disorders, most consistently
schizophrenia (Kopp & Rist, 1999; Alain et al. 2002;
Bates et al. 2002, 2004; Morris et al. 2006, 2008, 2011;
Mathalon et al. 2009; Foti et al. 2012; Horan et al.
2012; Perez et al. 2012; Simmonite et al. 2012;
Houthoofd et al. 2013; Kansal et al. 2014; Minzenberg
et al. 2014; de la Asuncion et al. 2015; Reinhart et al.
2015), but also bipolar disorder (Minzenberg et al.
2014; Morsel et al. 2014) (but see Kopf et al. 2015), aut-
ism spectrum disorders (Vlamings et al. 2008;
Sokhadze et al. 2010, 2012; South et al. 2010) (but see
Groen et al. 2008; Henderson et al. 2015) and various
forms of addiction (Forman et al. 2004; Franken et al.
2007; Sokhadze et al. 2008; Luijten et al. 2011; Zhou
et al. 2013) (but see Schellekens et al. 2010; Chen et al.
2013). Moreover, the amplitude of the ERN was found
to predict treatment adherence for substance abuse
(Steele et al. 2014) and decreases in the ERN are asso-
ciated with self-reported impulsivity (Potts et al. 2006).
Results in ADHD aremixedwith some studies showing
decreased ERN (Liotti et al. 2005; van Meel et al. 2007;
Groen et al. 2008; Herrmann et al. 2010; Groom et al.
2013), but most reporting no differences (Wiersema
et al. 2005, 2009; Groen et al. 2008; Wild-Wall et al.
2009; Zhang et al. 2009; Groom et al. 2010; Sokhadze
et al. 2012) and only one study reporting an increase
(Burgio-Murphy et al. 2007) (Table 1). Together, these
data provide convergent evidence that an enhancement
of the ERN is not ubiquitous in psychiatry, but rather
appears tobedirectionally speciﬁc todisorders character-
ized predominantly by anxiety. This therefore may con-
stitute a trans-diagnostic marker relevant for many
disorders involving anxiety, including OCD.
Validating a trans-diagnostic mechanism:
goal-directed learning and compulsivity
The suggestion that the consistent ﬁnding of enhanced
ERN in OCD in fact reﬂects a trans-diagnostic pheno-
type representing anxiety is perhaps a compelling
one given the pattern of results described above.
However, without direct comparison across disorders
and/or discrete symptom dimensions, conclusions
regarding its phenomenological speciﬁcity cannot be
drawn (indeed ‘anxiety’ is intended to serve as a place-
holder, until such work is complete). We will now
highlight an approach that can take this next step,
drawing on data from an independent line of research
in OCD. This body of research centres on the theory
that an imbalance between ‘goal-directed control’
and ‘habit-learning’ drives symptoms in OCD (see
Gillan & Robbins, 2014 for detailed account) (see
Supplementary material), such that compulsive beha-
viours in OCD are not goal-directed responses to anx-
iety/perceived threat, but are in fact stimulus-evoked,
goal-insensitive habits (Dickinson, 1985). This model
suggests that compulsions are not a search for safety;
they are a result of the need to realize a link that has
developed between a stimulus or context and a given
set of responses. In this view, the subjective experi-
ences that accompany habits, such as ‘not just right
experience’ (Coles et al. 2005; Ecker & Gönner, 2008),
or more complex obsessive thoughts are the result of
the compulsive urge, not the cause. For example,
there is preliminary evidence to suggest that obsessive
thoughts can even arise as a result of compulsive habit
formation in OCD, and not the other way around
(Gillan et al. 2014b; Gillan & Sahakian, 2015), constitut-
ing a sharp divergence from most cognitive models of
OCD that focus on obsessive thoughts (Salkovskis,
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Table 1. Summary of results for studies examining error-related negativity (ERN) across psychiatric disorders
Unmedicateda ERNb Sample size (case, control) Task
Obsessive-compulsive disorder
Gehring et al. (2000) : 9, 9 Stroop
Johannes et al. (2001b) × : 10, 10 Cued RT task
Ruchsow et al. (2005) : 11, 11 Go/NoGo
Nieuwenhuis et al. (2005) N.S. 16, 16 Probabilistic RL
Endrass et al. (2008) : 20, 20 Flanker
Hajcak et al. (2008)c : 18, 18 Simon
Endrass et al. (2010) : 22, 22 Flanker
Endrass et al. (2010) N.S. 22, 22 Flanker
Stern et al. (2010)d : 38, 40 Flanker
Xiao et al. (2011)e : 25, 27 Flanker
Riesel et al. (2011) : 30, 30 Flanker
Hanna et al. (2012)c : 44, 44 Flanker
Carrasco et al. (2013a)c : 40, 40 Flanker
Carrasco et al. (2013b)c,e,f : 26, 27 Flanker
Endrass et al. (2014)e : 24, 24 Flanker
Grützmann et al. (2014) : 20, 22 Flanker
Agam et al. (2014) N.S. 19, 16 Antisaccade task
Klawohn et al. (2014) : 26, 26 Flanker
Liu et al. (2014)c : 20, 20 Flanker
Mathews et al. (2015)e N.S. 27, 45 Flanker
(Riesel et al. (2015) : 41, 37 Flanker
Weinberg et al. (2015)e N.S. 26, 56 Flanker
Generalized anxiety disorder
Ladouceur et al. (2006)c,f × : 9, 10 Flanker
Weinberg et al. (2010) × : 17, 24 Flanker
Xiao et al. (2011)e N.S. 27, 27 Flanker
Weinberg et al. (2012)e × : 26, 36 Flanker
Carrasco et al. (2013b)c,e,f : 13, 27 Flanker
Weinberg et al. (2015)e : 57, 56 Flanker
Depression
Ruchsow et al. (2004) N.S. 16, 16 Flanker
Ruchsow et al. (2006) ; 10, 10 Go/NoGo
Chiu & Deldin (2007) : 18, 17 Flanker
Holmes & Pizzagalli (2008) × :: 20, 20 Stroop
Olvet et al. (2010) × N.S. 22, 22 Flanker
Holmes & Pizzagalli (2010) × : 18, 18 Stroop
Georgiadi et al. (2011)g : 19, 19 Go/NoGo
Georgiadi et al. (2011) N.S. 17, 17 Go/NoGo
Ladouceur et al. (2012)c × ; 24, 14 Flanker
Aarts et al. (2013) : 20, 20 Go/NoGo
Tang et al. (2013) × : 22, 24 Flanker
Mueller et al. (2015) × : 14, 15 Probabilistic RL
Weinberg et al. (2015)e N.S. 62, 56 Flanker
Other anxiety disorders
Clemans et al. (2012) [PTSD] ; 10, 10 Flanker
Rabinak et al. (2013) [PTSD] × N.S. 16, 16 Flanker
Endrass et al. (2014) [social]e : 24, 24 Flanker
Hoarding disorder
Mathews et al. (2015)e ; 14, 45 Flanker
Schizophrenia
Kopp & Rist (1999) ; 29, 18 Flanker
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Table 1 (cont.)
Unmedicateda ERNb Sample size (case, control) Task
Alain et al. (2002) ; 12, 12 Stroop
Bates et al. (2002) ; 21, 21 Go/NoGo
Bates et al. (2004) ; 9, 9 Go/NoGo
Morris et al. (2006) ; 16, 11 Flanker
Morris et al. (2008) ; 26, 27 Probabilistic RL
Mathalon et al. (2009) ; 11, 10 Go/NoGo
Morris et al. (2011) ; 20, 15 Flanker
Foti et al. (2012)e ; 33, 33 Flanker
Simmonite et al. (2012)h ; 29, 35 Go/NoGo
Horan et al. (2012) ; 16, 14 Flanker
Perez et al. (2012)h ; 84, 110 Matching
Houthoofd et al. (2013) ; 12,12 Flanker
Kansal et al. (2014) ; 18,18 Stroop
Minzenberg et al. (2014)e ; 73, 54 Stroop
de la Asuncion et al. (2015) ; 22, 21 Simon
Reinhart et al. (2015) ; 19, 18 Probabilistic RL
Bipolar disorder
Minzenberg et al. (2014)e ; 26, 54 Stroop
Kopf et al. (2015) N.S. 20, 18 Flanker
Morsel et al. (2014) ; 16, 14 Flanker
Addiction
Forman et al. (2004) [opiates] ; 13, 26 Go/NoGo
Chen et al. (2013) [opiates] N.S. 17, 15 Flanker
Franken et al. (2007) [cocaine] × ; 14, 13 Flanker
Sokhadze et al. (2008) [cocaine] ; 6, 6 Flanker
Schellekens et al. (2010) [alcohol] : 29, 15 Flanker
Luijten et al. (2011) [nicotine] × ; 13, 14 Flanker
Zhou et al. (2013) [internet] ; 23, 23 Flanker
Attention deﬁcit hyperactivity disorder
Liotti et al. (2005)c,i × ; 10, 10 Stop signal
Wiersema et al. (2005)c,i × N.S. 22, 15 Go/NoGo
van Meel et al. (2007) × ; 16, 16 Flanker
Jonkman et al. (2007) × N.S. 10, 10 Flanker
Burgio-Murphy et al. (2007)c,e,i × : 182, 60 Cued RT task
Burgio-Murphy et al. (2007)c,e × N.S. 77, 60 Cued RT task
Groen et al. (2008)c,e,i × ; 18, 18 Probabilistic RL
Groen et al. (2008)c,e,i ; 17, 18 Probabilistic RL
Wild-Wall et al. (2009)c,i N.S. 15, 12 Flanker
Zhang et al. (2009)c N.S. 14, 14 Go/NoGo
Wiersema et al. (2009) N.S. 23, 19 Go/NoGo
Groom et al. (2010)c,i × N.S. 23, 19 Go/NoGo
Herrmann et al. (2010)i × ; 34, 34 Flanker
Sokhadze et al. (2012)c,e N.S. 16, 16 Oddball
Groom et al. (2013)c,i × ; 28, 28 Go/NoGo
Groom et al. (2013)c,i N.S. 28, 28 Go/NoGo
Autism spectrum disorders
Groen et al. (2008)c,e × N.S. 18, 18 Probabilistic RL
Vlamings et al. (2008)c × ; 17, 10 Matching
South et al. (2010)h ; 24, 21 Flanker
Sokhadze et al. (2010)c ; 14, 14 Oddball
Sokhadze et al. (2012)c,e ; 16, 16 Oddball
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1985). The original habit hypothesis of OCD was based
on a convergence of neurobiological data illustrating
that the pathophysiology of OCD overlaps extensively
with that supporting the balance between goal-
directed behaviour and habits (Graybiel & Rauch,
2000; Dolan & Dayan, 2013). Empirical studies have
found broad support for this idea; OCD patients
show a reliable tendency to form habits excessively
in both appetitive and aversive learning contexts
(Gillan et al. 2011, 2014b). Based on convergent evi-
dence from follow-up investigations utilizing neuro-
imaging and computational modelling (Gillan et al.
2014a, 2015a; Voon et al. 2014), the working model the-
orizes that deﬁcits in goal-directed control, mediated
by the caudate and medial orbitofrontal cortex, are
responsible for the excessive habits observed in OCD
in the laboratory (Gillan & Robbins, 2014). Clinically,
these habits might manifest as compulsive behaviours
and/or higher-order habitual needs or goals (Cushman
& Morris, 2015).
Addressing the trans-diagnostic potential of this
neurocognitive mechanism, goal-directed control has
been suggested to play a role in a range of disorders
that are clinically characterized by repetitive beha-
viours that persist despite negative events, or are
experienced as ‘out of control’ (Gillan et al. 2016a).
These disorders include addiction (Everitt & Robbins,
2005), eating disorders (Godier & Park, 2014) and
Tourette’s syndrome (Groenewegen et al. 2003), and
although this area of research is still in its infancy,
the ﬁrst empirical investigations have found evidence
for goal-directed deﬁcits in these disorders (Sjoerds
et al. 2013; Voon et al. 2014; Delorme et al. 2015;
Ersche et al. 2016) (Table 2). As such, the candidacy of
goal-directed deﬁcits as a trans-diagnostic marker has
been acknowledged in the RDoC matrix, which ﬂags
several relevant theoretical domains, i.e. ‘Habit’, ‘Goal
Selection, Updating, Representation and Maintenance’
and ‘Response Selection, Inhibition or Suppression’.
However, studies have recently been published show-
ing similar deﬁcits in goal-directed control in schizo-
phrenia (Morris et al. 2015), autism spectrum disorder
(Alvares et al. 2016), and most problematically, social
anxiety disorder (Alvares et al. 2014, 2016), which is
not considered clinically to be a ‘compulsive’ disorder
(Table 2).
Using a case-control design, it is difﬁcult to disent-
angle a genuine lack of mechanistic speciﬁcity, as
these data might indicate, from ‘DSM measurement
error’, the confounding inﬂuence of co-morbid psychi-
atric disorders. For example, in the aforementioned
studies in social anxiety disorder patients (Alvares
et al. 2014, 2016), because patients presented with mul-
tiple co-morbid disorders, one cannot know if the
results are attributable to social anxiety symptoms or
one or more of their co-morbid conditions. Indeed,
like most disorders, OCD rates are higher in the social
anxiety population (Grant et al. 2005). To get around
this issue, some researchers (ourselves included) have
endeavoured to recruit only ‘pure cases’ of OCD, i.e.
those that do not meet the criteria for any other psychi-
atric diagnoses (Table 2). Although somewhat effect-
ive, the problem with this approach is that it assumes
that being one criterion short of diagnosis of depres-
sion, for example, is the same as having no depressive
symptoms at all. In reality, OCD patients recruited in
this way consistently have higher levels of sub-
threshold symptoms of multiple other disorders, e.g.
depression and anxiety (Gillan et al. 2011). While
these confounding variables could be controlled for
Table 1 (cont.)
Unmedicateda ERNb Sample size (case, control) Task
Henderson et al. (2015)c N.S. 38, 36 Flanker
N.S., Non-signiﬁcant; PTSD, post-traumatic stress disorder; RT, reaction time; RL, reinforcement learning.
a Unmedicated were free of selective serotonin re-uptake inhibitors or antipsychotics for at least 2 weeks, and free of
stimulants for 17 h. In the case of addiction, unmedicated applies when subjects meet the above criteria and are abstinent.
b Studies were included if they reported results of ERN analysis (either ERN or ERN corrected for correct-related negativity),
included a case-control comparison, and reported generic ERN effects using a task that could be compared across studies.
c Paediatric/adolescent sample.
d Compared medicated and unmedicated groups, and no medication effect was observed.
e Compared to other diagnoses in trans-diagnostic design.
f Mixed anxiety (mostly generalized anxiety disorder).
g Remitted patients.
hMixture adult and adolescent.
i Attention deﬁcit hyperactivity disorder combined-type only.
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statistically, most patient studies simply do not have
the necessary power to do so. Indeed, the difﬁculty
in recruiting sufﬁcient sample sizes for research studies
with patients is compounded by the increasing number
of (possibly confounding) disorders deﬁned by the
DSM in every new edition.
A novel solution to this problem was presented in a
recent study that eschewed the traditional case-control
design in favour of the greater sample sizes (and in
turn statistical power) that can be achieved by lever-
aging normal variability in a large general population
sample (Gillan et al. 2016b). The study tested if the rela-
tionship between goal-directed control and psycho-
pathology constitutes a trans-diagnostic trait by
testing its generalizability and speciﬁcity. Just under
2000 subjects were recruited online and completed self-
report questionnaires assessing multiple psychiatric
symptoms and completed a web-based task that
assessed goal-directed performance (i.e. ‘model-based
learning’; Daw et al. 2011). In line with the preceding
case-control literature, normal variation in self-
reported OCD symptomatology (Foa et al. 2002) was
associated with decreases in goal-directed control in
two separate samples collected in this study (also see
a recent independent replication: Snorrason et al.
2016). Importantly, this effect was generalizable to
symptoms of other aspects of compulsive psychopath-
ology (as previously characterized in the literature:
Everitt & Robbins, 2005; Hogarth et al. 2012; Godier
& Park, 2014). Speciﬁcally, eating disorders (Garner
et al. 1982), impulsivity (Patton et al. 1995) and alcohol
addiction (Saunders et al. 1993) were also associated
with deﬁcits in goal-directed control, suggestive of a
trans-diagnostic deﬁcit linking these disorders.
Crucially, these deﬁcits were not associated with
symptoms of trait anxiety (Spielberger et al. 1983),
depression (Zung, 1965), social anxiety (Liebowitz,
1987) or apathy (Marin et al. 1991). Schizotypy
Table 2. Summary of results for studies examining goal-directed learning
Unmedicateda Goal-directed control Sample size (case, control) Task
Obsessive compulsive disorder
Gillan et al. (2011) ; 20, 20 Devaluation
Gillan et al. (2014b) ; 25, 25 Devaluation
Gillan et al. (2014a) ; 20, 20 A-O learning
Voon et al. (2014)b × ; 32, 96 MB learning
Gillan et al. (2015a)c ; 37, 33 Devaluation
Social anxiety disorder
Alvares et al. (2014) ; 23, 23 Devaluation
Alvares et al. (2016)b ; 20, 19 Devaluation
Schizophrenia
Morris et al. (2015) ; 18, 18 Devaluation
Addiction
Sjoerds et al. (2013) [alcohol] ; 31, 19 A-O learning
Voon et al. (2014) [meth]b ; 22, 66 MB learning
Voon et al. (2014) [alcohol]b × N.S. 30, 90 MB learning
Ersche et al. (2016) [cocaine] ; 72, 53 Devaluation
Tourette syndrome
Delorme et al. (2016) × ; 17, 17 Devaluation
Delorme et al. (2016) N.S. 17, 17
Autism spectrum disorders
Geurts & de Wit (2013)d N.S. 24, 24 Devaluation
Alvares et al. (2016)b ; 17, 19 Devaluation
Eating disorders
Voon et al. (2014) [binge eating]b × ; 31, 93 MB learning
N.S., Non-signiﬁcant.
Goal-directed learning was measured using devaluation, model-based (MB) learning or action-outcome (A-O) learning test.
The latter two measures are proxies for devaluation sensitivity (Gillan et al. 2011, 2015b).
a Unmedicated were free of selective serotonin re-uptake inhibitors or antipsychotics for at least 2 weeks, and free of
stimulants for 17 h. In the case of addiction, unmedicated applies when subjects meet the above criteria and are abstinent.
b Compared multiple diagnostic groups.
c Compared medicated and unmedicated groups, and no medication effect was observed.
d Paediatric sample.
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(Mason et al. 2005) sat somewhere in the middle, show-
ing a marginal association with goal-directed deﬁcits
(Fig. 2a).
Although these results are suggestive of generalizabil-
ity and speciﬁcity, this kind of analysis does not take us
much further than work in diagnosed patients, save to
say that these effects appear to be continuous in the gen-
eral population rather than being speciﬁc to diagnosed
groups. A more important question is what the psychi-
atric phenotype that explains this pattern of results? Is
there a trans-diagnostic symptom dimension shared by
some disorders (e.g. OCD, addiction, eating disorders),
but not others (e.g. social anxiety, depression)? To answer
this question empirically, this study employed a two-
stage validation methodology. First, a factor analysis
was carried out on psychiatric self-report data to identify
a smaller set of clinical phenotypes that more parsimoni-
ously explain the self-report symptom data. This
approach revealed that three factors could replace the
nine original questionnaires and of particular interest
was a factor linking disorders at the level of compulsive
behaviour and thought, so-called ‘Compulsive Behaviour
and Intrusive Thought’. This factor comprised select fea-
tures of OCD, eating disorders, addiction and some
aspects of impulsivity and schizotypy that pertain to a
loss of control over repetitive behaviour and thought.
Next, this phenotype was tested for biological validity
by assessing if subjects’ scores on this factor predicted
goal-directed performance in an independent analysis.
‘Compulsive Behaviour and Intrusive Thought’ was
found to be more predictive of goal-directed deﬁcits
than any DSM-inspired questionnaire collected in this
study (Fig. 2b), illustrating the power of data-driven
clinical phenotyping. For example, this trans-diagnostic
symptom dimension predicted task performance better
than total scores on questionnaires measuring severity
of DSM disorders such as OCD, eating disorders
and addiction. Crucially, this relationship was dissociable
from other trans-diagnostic phenotypes identiﬁed in this
study, ‘Anxious-Depression’ and ‘Social Withdrawal’
(which showed no relation to goal-directed deﬁcits),
which could be compared directly in this study, provid-
ing compelling evidence for the speciﬁcity of this deﬁcit
to ‘Compulsive Behaviour and Intrusive Thought’. This
approach showcases how in an appropriately powered
general population sample, a neurocognitive model can
be tested for both generalizability and speciﬁcity, leading
to a data-driven deﬁnition of a neurobiologically vali-
dated clinical phenotype.
Going deeper: ‘units of analysis’
In tandem with new approaches to empirically deﬁne
psychiatric phenotypes, the task for basic research is
to delineate the neurobiology that underpins them.
RDoC proposes that this should be done, where appro-
priate, using units of analysis that link clinical phenom-
enology (e.g. self-reports) to behaviour/physiology (via
paradigms) to the underlying circuit, cells, molecules
and ﬁnally, genes. The aims of this approach are to
Fig. 2. Validating a trans-diagnostic dimension. (a) The strength of the association between self-report symptoms of various
DSM disorders and deﬁcits in goal-directed control. The pattern is strikingly non-speciﬁc. (b) The association between
goal-directed deﬁcits and three ‘trans-diagnostic symptom dimensions identiﬁed in a data-driven factor analysis. Factor 1
corresponds to ‘Anxious Depression’, Factor 2 is ‘Compulsive Behavior and Intrusive Thought’, and Factor 3 is ‘Social
Withdrawal’. The association between Factor 2 (‘Compulsive Behavior and Intrusive Thought’) and deﬁcits in goal-directed
learning is greater than that of any of the nine DSM-inspired questionnaires and crucially, the relationship exhibits excellent
speciﬁcity with respect to ‘non-compulsive’ aspects of psychopathology, i.e. Factor 1 (‘Anxious Depression’) and Factor 3
(‘Social Withdrawal’). Data reproduced with permission from Gillan et al. (2016b). *p < 0.05, **p < 0.01, ***p < 0.001.
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facilitate evidence-based drug-development (e.g. based
on pharmacological underpinnings), to guide new
therapeutic approaches such as psychological therapies
(e.g. based on neurocognitive changes) or brain stimu-
lation (e.g. based on knowledge of brain circuits), and
to identify and treat those at risk (e.g. using genetic
tests) (Fig. 3).
Here, we will highlight just a couple of examples
drawing on units of analysis that have the most direct
implications for treatment. Might the ERN be useful
for deciding on which treatment to prescribe to
which individual? To begin to answer this, we must
review what is known about the pharmacology of
the ERN (i.e. as a molecular unit of analysis).
Benzodiazepines, speciﬁcally alprazolam (Riba et al.
2005), lorazepam (de Bruijn et al. 2004) and oxazepam
(Johannes et al. 2001a), reduce the amplitude of the
ERN. This suggests a potential role for GABA (which
is thought to directly inhibit ACC functioning) in the
ERN and with that, a putative biological basis for the
therapeutic effect of these drugs for GAD and therefore
plausibly also for anxiety as a trans-diagnostic trait
(Ravindran & Stein, 2010). Unfortunately, this theory
runs into issues when one considers that benzodiaze-
pines are ineffective for treating OCD (e.g. clonazepam,
Hollander et al. 2003). Moreover, antidepressants, such
as paroxetine and mirtazapine, which appear to have
no effect on the ERN (de Bruijn et al. 2004, 2006), have
good efﬁcacy for treating both OCD and GAD. This
apparent lack of pharmacological speciﬁcity is com-
pounded by research on dopamine, which is probably
been the most studied neurotransmitter with respect to
the ERN. Studies in this area have shown that amphet-
amine administration increases the amplitude of the
ERN (de Bruijn et al. 2004), while antipsychotics such
as haloperidol and olanzapine reduce it (Zirnheld et al.
2004; de Bruijn et al. 2006). Although antipsychotics
can be useful for OCD in particularly treatment resistant
cases, GAD does not respond to antipsychotics
(Ravindran & Stein, 2010).
Thus, the question of how an ERN measurement can
help inform treatment response across disorders is far
from clear. It may be the case that combined measures,
such as ERN, structural scans and self-report, are
needed to produce a useful therapeutic signal. For
example, although the core symptoms of OCD do
not typically reduce following benzodiazepines, this
drug class might be useful for decreasing anxiety in
certain OCD patients – and these particularly anxious
patients might be driving the ERN ﬁndings from stud-
ies examining this patient population at the group
level. Alternatively, the ERN might have no speciﬁc
causal role for psychiatry whatsoever, it might arise
from a range of discrete upsets to neural harmony –
longitudinal designs are needed to answer these ques-
tions deﬁnitively.
Fig. 3. A trans-diagnostic approach to obsessive-compulsive disorder (OCD). The predominant symptoms of OCD may result
from complex interaction between independent trans-diagnostic dimensions, of which anxiety and compulsivity are good (but
not the only) candidates. In this simpliﬁed schematic, we show just two putative trans-diagnostic psychiatric dimensions,
there are of course many others. The task for basic research, outlined in the Research Domain Criteria initiative is to
understand these dimensions at units of analysis, linking self-report symptoms (such as anxiety and compulsivity) to
paradigms, physiology, circuits, cells, molecules and genes. GAD, Generalized anxiety disorder.
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Turning to circuits, cells and the link between
self-report compulsivity and deﬁcits in goal-directed
control (Gillan et al. 2016b), studies point to the involve-
ment of the medial orbitofrontal cortex (mOFC) and
caudate based on their involvement in goal-directed
control across species (Dolan & Dayan, 2013) and con-
vergent data suggesting these are critically involved in
OCD and other compulsive disorders. For example,
hyperactivity in the caudate nucleus is linked to failures
in goal-directed behaviour observed in OCD patients
(Gillan et al. 2015a). In terms of brain structure, deﬁcits
in goal-directed control are associated with reductions
of grey-matter volume in the caudate and mOFC in
healthy individuals (Voon et al. 2014). Moreover, in
this same study, the observation that these regional
volumes are reduced in binge-eating disorder patients
was statistically explained by their deﬁcits of goal-
directed control relative to controls (Voon et al. 2014).
Although imaging studies in humans are important
for validating animal models of psychiatric popula-
tions, animal models are crucial as they can uniquely
assess causality (Ahmari, 2015). To this end, one exem-
plary study showed that chronic stimulation of mOFC
neurons that project to the ventromedial striatum [i.e.
mimicking the hyperactivity observed in human OCD
patients (Gillan et al. 2015a)] induces compulsive
grooming behaviour in mice (Ahmari et al. 2013).
Furthermore, the authors found that excessive groom-
ing was ameliorated with chronic SSRI treatment, the
ﬁrst line pharmacotherapy for OCD (Fineberg et al.
2013b), thereby showing convergence across multiple
units of analysis, from behaviour to brain circuits to
molecules. What remains to be seen is whether this
kind of chronic stimulation also induces deﬁcits in goal-
directed control in tandem with compulsive grooming,
and if deﬁcits in goal-directed control are remediated
by treatment with SSRIs. These are testable hypotheses
that, if supported, could mean that computerized tasks
that assess this neurocognitive mechanism might be
used to inform treatment allocation in the future. In
addition to guiding pharmacotherapy decisions, work
at the circuit level can be used to select target sites for
deep-brain stimulation, of which there are many candi-
dates for OCD (Mallet et al. 2008; Nuttin et al. 2008;
Denys et al. 2010; Greenberg et al. 2010) and indeed to
guide the allocation of distinct forms of behavioural
therapy (Saxena et al. 2009). The question of whether
deﬁcits in goal-directed control diminish with success-
ful treatment (and are akin to state phenomena) or
remain elevated and stable (trait) awaits investigation.
But even more interesting in our minds is the question
of whether or not goal-directed performance at baseline
predicts better response to one treatment over another.
This may be how the success of the marker should be
ultimately judged.
Precision therapeutics: insights and trans-diagnostic
opportunities
Although deﬁning biologically valid clinical pheno-
types as accurately and discretely as possible is valu-
able, it may not be the most important thing that
trans-diagnostic psychiatry research can contribute.
Even if a phenotype such as ‘compulsivity’ possesses
good neurobiological validity, speciﬁcity and homo-
geneity, this may not translate into homogeneity of
treatment response. Rather, discrete neural patho-
physiology may give rise to common network-level
dysfunctions and behavioural manifestations, and
these distal phenotypic markers might therefore offer
minimal insight for clinicians in deciding on whether
or not an SSRI will be effective in an individual. One
way to address this is to work from the bottom-up –
to take a step back from phenotypic classiﬁcation and
focus instead on establishing robust and direct links
between neurocognitive markers and treatment
response. This kind of work has already begun, typic-
ally within the conﬁnes of one diagnostic category or
another and we will brieﬂy mention some of the
most promising data. We will take a particular focus
on pharmacological interventions, but the general
approach can similarly be applied to behavioural inter-
ventions. Then we will highlight how treatment pre-
diction research involving sufferers of many DSM
categories that are prescribed the same treatment is
likely to be an important approach of the future.
Taking neural markers as an example, several studies
have had early success at using functional imaging at
the group level to predict treatment response within
the OCD population (for review see Ball et al. 2014).
One potential marker of SRI response in OCD is
reduced baseline activity in the OFC and ACC (Swedo
et al. 1992, 1989; Brody et al. 1998; Saxena et al. 1999).
Unfortunately several studies that came later failed to
replicate (Saxena et al. 2003; Carey et al. 2004; Ho Pian
et al. 2005; van der Wee et al. 2007), ﬁnding no signiﬁ-
cant effects or in some cases entirely different neural
markers. A recent study tested whether a task-related
ACC measure like ERN might fare better than these
resting studies at predicting clinical response.
Although the result should be taken cautiously as the
sample size was particularly small (only 10 patients
returned at post-treatment assessment), the authors
were unable to ﬁnd a relationship between baseline
ERN and cognitive behaviour therapy response in a
paediatric OCD sample (Hajcak et al. 2008).
One possibility is that the predictive value of ACC
activity (if there is any) could be exclusive to a putative
anxiety dimension and this might get washed out in
studies relying on heterogeneous diagnostic categories
and small samples. Recruiting large samples across
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diagnostic categories and recording changes in the
symptoms of dissociable psychiatric dimensions like
anxiety and compulsivity might help isolate reliable
effects. Indeed, in the one study that adopted a trans-
diagnostic approach, recruiting individuals with
OCD, depression or both, the authors were able to
identify dissociable neural markers of subsequent
depressive v. obsessive-compulsive response to parox-
etine (Saxena et al. 2003). This means that not only is
the same drug effective in treating distinct psychiatric
problems, its efﬁcacy at treating depression and OCD
symptoms (sometimes in the same individual) is pre-
dicted by dissociable patterns of abnormal baseline
neural activity. Given that individuals with a diagnosis
of OCD are aetiologically and phenotypically heteroge-
neous, the task for future research is not to identify
mean baseline activity patterns in responders v. non-
responders on some singular measure of function,
but to use large datasets to tease apart the mechanisms
through which a given drug can reduce symptoms of
largely independent psychiatric dimensions, and use
these insights to identify the patients for whom a
symptom reduction is likely to happen following
treatment.
To conclude this section with some practical state-
ments, morphometric predictors of SRI response in
OCD already appear to be somewhat more robust
than functional ones. The only two structural MRI
studies to date have both shown that decreased grey
matter in the lateral OFC is also linked to SRI response
(Hoexter et al. 2013, 2015). Hoexter and colleagues
showed that OFC grey-matter volume had 77% sensi-
tivity and 81% speciﬁcity at predicting SRI response
in OCD. If these ﬁgures hold up to replication using
the same analysis pipeline, the interpretation is that if
this marker were used to determine whether or not
an SRI is prescribed to a drug-naive individual, just
two out of every 10 people assigned to SSRI would
not respond, while another two of the 10 not assigned
the treatment would have missed out on the beneﬁts of
the SSRI (Hoexter et al. 2015). This would make it a
useful tool for clinicians, were MRI scans not expensive
and impractical for most clinics to use diagnostically
(at least for now). This is where we suggest cognitive
neuroscience might be able to intervene by replacing
brain scans with cognitive tasks that are good indica-
tors of neurobiology, such those linked to normal
and pathological variation in OFC grey-matter volume,
of which goal-directed control is one notable example
(Voon et al. 2014). Cognitive behavioural therapy for
OCD similarly might beneﬁt from the addition of com-
ponents that focus more directly on habit formation and
goal-directed control in those patients for whom it is
more relevant. For example, one might focus psychoe-
ducation: patients could be taught about identifying
habit ‘trigger’ situations, or identifying the development
of new habits that might later develop into more
elaborate compulsions. Alternatively, habit-reversal
training (Snorrason et al. 2015) may be used to comple-
ment standard exposure and response prevention tech-
niques. These behavioural treatments might be further
enhanced with targeted pharmacotherapy, for which
basic data are accruing (Lovinger, 2010).
Combining trans-diagnostic with existing approaches
We have argued strongly in favour of the trans-
diagnostic model as a rational approach to advance
basic science research in psychiatry, but must make
clear that to date this approach has yet to facilitate
gene discovery or the development of new, better treat-
ments. It will take time for sufﬁcient data to accrue and
as such, dismissing symptom-based approaches
entirely is premature. Existing clinical trial datasets,
based on patients grouped according to conventional
diagnostic criteria such as DSM, have demonstrated a
clear speciﬁcity of effect for certain psychiatric treat-
ments [e.g. serotonin v. noradrenaline reuptake inhibi-
tors in OCD (Fineberg et al. 2014)], and a magnitude of
efﬁcacy for some of our treatments commensurate with
the effect sizes seen in other branches of medicine
(Davis et al. 2011; Leucht et al. 2015). We have also
seen that speciﬁc drug response can be linked to easily
observable symptoms, such as the presence of tics
(Bloch et al. 2006). The hope is that by revisiting how
we deﬁne disorder and/or dimensions using biological
and cognitive data will further enhance the precision
with which treatments can be delivered to individuals.
In addition, new ways of assessing the outcomes of
treatment trials, e.g. using statistical techniques such
as group-based mixture models, that divide ‘diagnos-
tic’ patient samples into clinically meaningful sub-
groups with greater predictive value, hold promise
for the advancement of personalized psychiatric treat-
ment (Thase et al. 2011). Thus, most progress is likely to
be made with a balanced approach, taking into account
and if possible combining the most valid and reliable
diagnostic and trans-diagnostic methodologies.
Conclusion
This paper presented a trans-diagnostic perspective on
OCD – a diagnostic category – that selectively focused
on just two putative mechanisms relevant for our
understanding of anxiety and compulsivity in OCD.
These candidate mechanisms illustrate how two
orthogonal trans-diagnostic mechanisms might con-
verge to produce a phenotype that is currently
deﬁned as a unitary category. Speciﬁcally, avoidance
compulsions, obsessions and anxiety are the deﬁning
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clinical features of OCD according to DSM-5 (APA,
2013). As the symptom complex that this triad pro-
duces is unlikely to be underpinned by one speciﬁc
cognitive/neural mechanism, breaking OCD down
into orthogonal trans-diagnostic mechanisms may be
of beneﬁt for developing translational models – par-
ticularly for animal models that are crucial for causal
mechanistic investigations. This research initiative has
just begun for OCD, and many candidate dimensions
await empirical validation or rejection. This can be
achieved in many different ways, just a few of which
have been outlined here (see other good examples:
Fair et al. 2012; Brodersen et al. 2014), and at many
units of analysis. Most importantly, psychiatric diag-
nostic tools of the future must focus on maximizing
predictive value, reﬁning treatment allocation (both
behavioural and pharmacological), identifying pro-
spects and tools for early intervention, determining
risk and clinical course. To do this, we need a new
wave of focused longitudinal studies in psychiatry
that can assess which cognitive tests or neural markers
possess the most clinically useful properties. While
studies of this kind have been historically difﬁcult to
conduct, costly and complicated, the ﬁeld is already
rising to the challenge by developing new methodolo-
gies (Brodersen et al. 2014; Gillan & Daw, 2016) that
will help us to put biological psychiatry to the clinical
test.
Supplementary material
The supplementary material for this article can be
found at https://doi.org/10.1017/S0033291716002786.
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